Bias etc. [NCA / SHAM]

posted by Helmut Homepage – Vienna, Austria, 2019-02-16 15:26 (2056 d 18:43 ago) – Posting: # 19929
Views: 12,322

Hi ElMaestro

❝ […] remember that when we do BE we treat T and R in the same fashion. So regardless of how terrible we bias some estimate we may do that equally for the two treatments we are comparing.


Reads nice on paper but people might be tempted to fiddle around if they are already unblinded before performing NCA. Hence, my sequence is:
  1. Import necessary data (doses, dosing times, actual sampling time points, measured concentrations).
  2. Perform NCA in a blinded manner (in PHX-lingo: Sort the dataset by subject and period).
  3. Lock the results.
  4. Import the randomization and join the respective tables.
Actually I even don’t have the randomization beforehand. I ask the sponsor or CRO for it after #3. Hence, nobody can blame me that I didn’t “treat T and R in the same fashion”.

❝ […] there was a post recently (Mittyri? Hötzi? Someone else?) …


Myself for sure. I’m notorious for that.

❝ … who wrote that when we do log down in BE we assume a first order elimination.


Yep.

❝ That is much a personal interpretation, I think. When I do log or linear down in BE, I am personally only saying I am willing to make the same error for T and R regardless of how the drug is eliminated, full stop :-)


Agree, if (!) there are no missings. OK, one exception: Same time point missing in the same subject.

❝ Even if the SPC or FOI info indicates first order elimination I am perfectly fine with lin. down especially if this is what the CRO usually does well. Wouldn't want them to get out of their comfort zone.


If the linear trapezoidal defines the comfort zone of a CRO it disqualifies itself (linear-up / log-down is implemented in software for ages). If someone isn’t able to RTFM and push yet another button, well…

❝ From the top of my head, I believe I have never been in a situation where I needed to defend an AUC value per se, …


Not AUC but I was once asked whether my software for NCA was validated (see there). Funny enough, the agency asked for cross-validation [sic] against “commercial software like WinNonlin” as if commercical software is the gold standard.

❝ Regulators are using PHX now????


The FDA does (modeling). The Saudia FDA does (BE, though additionally to SAS).

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,240 posts in 4,884 threads, 1,653 registered users;
69 visitors (0 registered, 69 guests [including 10 identified bots]).
Forum time: 11:09 CEST (Europe/Vienna)

[The] impatience with ambiguity can be criticized in the phrase:
absence of evidence is not evidence of absence.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5